A new study being used to call for mifepristone restrictions relies on vague and dubious definitions of drug-related complications.

Elizabeth Nolan Brown
May 5, 2025

The abortion pill mifepristone "is not safe and effective," argue the authors of a new study that uses insurance claim data to examine adverse reactions to the pill. They claim to have found a "serious adverse event" rate of 10.93 percent, and they say this finding justifies renewed restrictions on mifepristone.

Sen. Josh Hawley (R–Mo.) seems to agree. The day the Ethics & Public Policy Center (EPPC) released its new mifepristone study, Hawley wrote to Food and Drug Administration (FDA) chief Marty Makary, urging the commissioner to "follow this new data and take all appropriate action to restore critical safeguards on the use of mifepristone."

Continued: https://reason.com/2025/05/05/the-bad-data-backing-josh-hawleys-attack-on-abortion-pills/